Curis
CRIS
#11066
Rank
โ‚ฌ4.07 M
Marketcap
0,43ย โ‚ฌ
Share price
-23.59%
Change (1 day)
-56.27%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -12,53ย โ‚ฌ

According to Curis's latest financial reports the company's current EPS (TTM) is -12,97ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -21,72ย โ‚ฌ an increase over its 2024 EPS that were of -128,24ย โ‚ฌ.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-12,53ย โ‚ฌ-42.3%
2025-21,72ย โ‚ฌ-83.07%
2024-128,24ย โ‚ฌ-22.15%
2023-164,73ย โ‚ฌ-26.17%
2022-223,10ย โ‚ฌ22.3%
2021-182,42ย โ‚ฌ-25.37%
2020-244,44ย โ‚ฌ-30.93%
2019-353,89ย โ‚ฌ-2.02%
2018-361,19ย โ‚ฌ
2016-820,89ย โ‚ฌ-10%
2015-912,10ย โ‚ฌ138.1%
2014-383,08ย โ‚ฌ40%
2013-273,63ย โ‚ฌ-25%
2012-364,84ย โ‚ฌ66.67%
2011-218,90ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,65ย โ‚ฌ-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,33ย โ‚ฌ-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
3,16ย โ‚ฌ-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,97ย โ‚ฌ-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-2,90ย โ‚ฌ-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-4,60ย โ‚ฌ-64.56%๐Ÿ‡บ๐Ÿ‡ธ USA